SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Varga J, Abraham D.Systemic sclerosis: a prototypic multisystem fibrotic disorder.J Clin Invest2007;117:55767.
  • 2
    Dinkler M.Zur lehre von der sklerodermie.Deutsch Arch Klin Med1891;48:51477.
  • 3
    Campbell PM, LeRoy EC.Pathogenesis of systemic sclerosis: a vascular hypothesis.Semin Arthritis Rheum1975;4:35168.
  • 4
    Wigley FM.Raynaud's phenomenon.N Engl J Med2002;347:10018.
  • 5
    Avouac J, Fransen J, Walker UA, Riccieri V, Smith V, Muller C, et al.Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.Ann Rheum Dis2011;70:47681.
  • 6
    Kahaleh BM.Vascular involvement in systemic sclerosis.Clin Exp Rheumatol2004;22:S1923.
  • 7
    Kahaleh B, Mulligan-Kehoe MJ. Mechanisms of vascular disease. In: Varga J, Denton CP, Wigley FM, editors.Scleroderma: from pathogenesis to comprehensive management.London:Springer-Verlag;2012. p.22746.
  • 8
    Kahaleh B, Matucci-Cerinic M.Raynaud's phenomenon and scleroderma: dysregulated neuroendothelial control of vascular tone.Arthritis Rheum1995;38:14.
  • 9
    Beyer C, Schett G, Gay S, Distler O, Distler JH.Hypoxia in the pathogenesis of systemic sclerosis.Arthritis Res Ther2009;11:220.
  • 10
    Hachulla E, Clerson P, Launay D, Lambert M, Morell-Dubois S, Queyrel V, et al.Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.J Rheumatol2007;34:242330.
  • 11
    Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al.Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research Group database.Ann Rheum Dis2007;66:75463.
  • 12
    Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, et al.Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions.Rheumatology (Oxford)2010;49:137482.
  • 13
    Nihtyanova SI, Brough GM, Black CM, Denton CP.Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis.Ann Rheum Dis2008;67:1203.
  • 14
    Berezne A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A, et al.Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers.Arthritis Care Res (Hoboken)2011;63:27785.
  • 15
    Walker JG, Stirling J, Beroukas D, Dharmapatni K, Haynes DR, Smith MD, et al.Histopathological and ultrastructural features of dermal telangiectasias in systemic sclerosis.Pathology2005;37:2205.
  • 16
    Shah AA, Wigley FM, Hummers LK.Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension.J Rheumatol2010;37:98104.
  • 17
    Duchini A, Sessoms SL.Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome.Am J Gastroenterol1998;93:14536.
    Direct Link:
  • 18
    Khanlou H, Malhotra A, Friedenberg F, Rothstein K.Jejunal telangiectasias as a cause of massive bleeding in a patient with scleroderma.Rev Rheum Engl Ed1999;66:11921.
  • 19
    Vautier G, McDermott E, Carty JE, Scott BB.Small bowel telangiectasia in scleroderma [abstract].Ann Rheum Dis1995;54:78.
  • 20
    Ingraham KM, O'Brien MS, Shenin M, Derk CT, Steen VD.Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors.J Rheumatol2010;37:6037.
  • 21
    Elkayam O, Oumanski M, Yaron M, Caspi D.Watermelon stomach following and preceding systemic sclerosis.Semin Arthritis Rheum2000;30:12731.
  • 22
    Mould TL, Roberts-Thomson PJ.Pathogenesis of telangiectasia in scleroderma.Asian Pac J Allergy Immunol2000;18:195200.
  • 23
    Carpentier P, Maricq H.Microvasculature in systemic sclerosis.Rheum Dis Clin North Am1990;16:7591.
  • 24
    Grassi W, Medico PD, Izzo F, Cervini C.Microvascular involvement in systemic sclerosis: capillaroscopic findings.Semin Arthritis Rheum2001;30:397402.
  • 25
    Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al.Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis.Arthritis Rheum2008;58:390212.
  • 26
    Cutolo M, Sulli A, Pizzorni C, Accardo S.Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis.J Rheumatol2000;27:15560.
  • 27
    Smith V, Pizzorni C, De Keyser F, Decuman S, Van Praet J, Deschepper E, et al.Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a bi-centre study.Ann Rheum Dis2010;69:10926.
  • 28
    Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, et al.Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study.Ann Rheum Dis2012;71:16369.
  • 29
    Alivernini S, De Santis M, Tolusso B, Mannocci A, Bosello SL, Peluso G, et al.Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing.J Am Acad Dermatol2009;60:42635.
  • 30
    Sebastiani M, Manfredi A, Vukatana G, Moscatelli S, Riato L, Bocci M, et al.Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study.Ann Rheum Dis2012;71:6770.
  • 31
    Hofstee HM, Noordegraaf AV, Voskuyl AE, Dijkmans BA, Postmus PE, Smulders YM, et al.Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis.Ann Rheum Dis2009;68:1915.
  • 32
    Ong YY, Nikoloutsopoulos T, Bond CP, Smith MD, Ahern MJ, Roberts-Thomson PJ.Decreased nailfold capillary density in limited scleroderma with pulmonary hypertension.Asian Pac J Allergy Immunol1998;16:816.
  • 33
    Kahan A, Coghlan G, McLaughlin V.Cardiac complications of systemic sclerosis.Rheumatology (Oxford)2009;48 Suppl 3:iii458.
  • 34
    Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, et al.Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.J Rheumatol2008;35:45865.
  • 35
    Dorfmuller P, Humbert M, Perros F, Sanchez O, Simonneau G, Muller KM, et al.Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases.Hum Pathol2007;38:893902.
  • 36
    Overbeek MJ, Vonk MC, Boonstra A, Voskuyl AE, Vonk-Noordegraaf A, Smit EF, et al.Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy.Eur Respir J2009;34:3719.
  • 37
    Humbert M, Sitbon O, Simonneau G.Treatment of pulmonary arterial hypertension.N Engl J Med2004;351:142536.
  • 38
    Shah JS.Genetics of systemic sclerosis associated pulmonary arterial hypertension; recent progress and current concepts.Curr Rheumatol Rep2009;11:8996.
  • 39
    Wipff J, Dieude P, Guedj M, Ruiz B, Riemekasten G, Cracowski JL, et al.Association of a KCNA5 gene polymorphism with systemic sclerosis–associated pulmonary arterial hypertension in the European Caucasian population.Arthritis Rheum2010;62:3093100.
  • 40
    Batal I, Domsic RT, Medsger TA Jr, Bastacky S.Scleroderma renal crisis: a pathology perspective.Int J Rheumatol2010;2010:543704.
  • 41
    Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC.The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.Medicine (Baltimore)1974;5:146.
  • 42
    Rodnan GP, Myerowitz RL, Justh GO.Morphologic changes in the digital arteries of patients with progressive systemic sclerosis (scleroderma) and Raynaud phenomenon.Medicine (Baltimore)1980;59:393408.
  • 43
    Taylor MH, McFadden JA, Bolster MB, Silver RM.Ulnar artery involvement in systemic sclerosis (scleroderma).J Rheumatol2002;29:1026.
  • 44
    Bartoli F, Blagojevic J, Bacci M, Fiori G, Tempestini A, Conforti MI, et al.Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis.Ann N Y Acad Sci2007;1108:28390.
  • 45
    Szucs G, Timar O, Szekanecz Z, Der H, Kerekes G, Szamosi S, et al.Endothelial dysfunction precedes atherosclerosis in systemic sclerosis—relevance for prevention of vascular complications.Rheumatology (Oxford)2007;46:75962.
  • 46
    Rosato E, Gigante A, Barbano B, Cianci R, Molinaro I, Pisarri S, et al.In systemic sclerosis macrovascular damage of hands digital arteries correlates with microvascular damage.Microvasc Res2011;82:4105.
  • 47
    Vettori S, Maresca L, Cuomo G, Abbadessa S, Leonardo G, Valentini G.Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment.Scand J Rheumatol2010;39:4859.
  • 48
    Sherer Y, Matucci Cerinic M, Bartoli F, Blagojevic J, Conforti ML, Gilburd B, et al.Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis.Ann N Y Acad Sci2007;1108:25967.
  • 49
    Bartoli F, Angotti C, Fatini C, Conforti ML, Guiducci S, Blagojevic J, et al.Angiotensin converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis.Rheumatology (Oxford)2007;46:7725.
  • 50
    Montisci R, Vacca A, Garau P, Colonna P, Ruscazio M, Passiu G, et al.Detection of early impairment of coronary flow reserve in patients with systemic sclerosis.Ann Rheum Dis2003;62:8903.
  • 51
    D'Angelo WA, Fries JF, Masi AT, Shulman LE.Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls.Am J Med1969;46:42840.
  • 52
    Akram MR, Handler CE, Williams M, Carulli MT, Andron M, Black CM, et al.Angiographically proven coronary artery disease in scleroderma.Rheumatology (Oxford)2006;45:13958.
  • 53
    Ngian GS, Sahhar J, Proudman SM, Stevens W, Wicks IP, Van Doornum S.Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis.Ann Rheum Dis2012;71:19803.
  • 54
    Turiel M, Gianturco L, Ricci C, Sarzi-Puttini P, Tomasoni L, De Gennaro Colonna V, et al.Silent cardiovascular involvement in patients with diffuse scleroderma: a controlled cross-sectional study.Arthritis Care Res (Hoboken)2013;65:27480.
  • 55
    Fleischmajer R, Perlish JS, Shaw KV, Pirozzi DJ.Skin capillary changes in early systemic scleroderma: electron microscopy and “in vitro” autoradiography with tritiated thymidine.Arch Dermatol1976;112:15537.
  • 56
    Fleischmajer R, Perlish JS.Capillary alterations in scleroderma.J Am Acad Dermatol1980;2:16170.
  • 57
    Sgonc R, Gruschwitz MS, Dietrich H, Recheis H, Gershwin ME, Wick G.Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma.J Clin Invest1996;98:78592.
  • 58
    Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, et al.Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.J Exp Med1998;188:135968.
  • 59
    Greeno EW, Bach RR, Moldow CF.Apoptosis is associated with increased cell surface tissue factor procoagulant activity.Lab Invest1996;75:2819.
  • 60
    Rajkumar VS, Sundberg C, Abraham DJ, Rubin K, Black CM.Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis.Arthritis Rheum1999;42:93041.
  • 61
    Zvaifler NJ.Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases.Arthritis Res Ther2006;8:210.
  • 62
    Li Z, Jimenez SA.Protein kinase Cδ and c-Abl kinase are required for transforming growth factor β induction of endothelial– mesenchymal transition in vitro.Arthritis Rheum2011;63:247383.
  • 63
    Bielecki M, Kowal K, Lapinska A, Chwiesko-Minarowska S, Chyczewski L, Kowal-Bielecka O.Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease.Adv Med Sci2011;56:25563.
  • 64
    Manetti M, Guiducci S, Romano E, Ceccarelli C, Bellando-Randone S, Conforti ML, et al.Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis.Circ Res2011;109:e1426.
  • 65
    Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, et al.Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro.Ann Rheum Dis2011;70:201121.
  • 66
    Allanore Y, Borderie D, Lemarechal H, Ekindjian OG, Kahan A.Nifedipine decreases sVCAM-1 concentrations and oxidative stress in systemic sclerosis but does not affect the concentrations of vascular endothelial growth factor or its soluble receptor 1.Arthritis Res Ther2004;6:R30914.
  • 67
    Avouac J, Wipff J, Goldman O, Ruiz B, Couraud PO, Chiocchia G, et al.Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor–derived cells under hypoxic conditions.Arthritis Rheum2008;58:355061.
  • 68
    Choi JJ, Min DJ, Cho ML, Min SY, Kim SJ, Lee SS, et al.Elevated vascular endothelial growth factor in systemic sclerosis.J Rheumatol2003;30:152933.
  • 69
    Avouac J, Cagnard N, Distler JH, Schoindre Y, Ruiz B, Couraud PO, et al.Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells.Arthritis Rheum2011;63:355262.
  • 70
    Nevskaya T, Bykovskaia S, Lyssuk E, Shakhov I, Zaprjagaeva M, Mach E, et al.Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations.Clin Exp Rheumatol2008;26:4219.
  • 71
    Del Papa N, Quirici N, Scavullo C, Gianelli U, Corti L, Vitali C, et al.Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis.J Rheumatol2010;37:205363.
  • 72
    Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, et al.Impairment of endothelial cell differentiation from bone marrow–derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.Arthritis Rheum2007;56:19942004.
  • 73
    Kuwana M, Okazaki Y, Kaburaki J.Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis.Mod Rheumatol2009;19:5305.
  • 74
    Furukawa S, Yasuda S, Amengual O, Horita T, Atsumi T, Koike T.Protective effect of pravastatin on vascular endothelium in patients with systemic sclerosis: a pilot study.Ann Rheum Dis2006;65:111820.
  • 75
    Ishigatsubo Y, Ihata A, Kobayashi H, Hama M, Kirino Y, Ueda A, et alTherapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells.Mod Rheumatol2010;20:26372.
  • 76
    Guiducci S, Porta F, Saccardi R, Guidi S, Ibba-Manneschi L, Manetti M, et al.Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report.Ann Intern Med2010;153:6504.
  • 77
    Lauber K, Bohn E, Krober SM, Xiao YJ, Blumenthal SG, Lindemann RK, et al.Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal.Cell2003;113:71730.
  • 78
    Laplante P, Sirois I, Raymond MA, Kokta V, Beliveau A, Prat A, et al.Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis.Cell Death Differ2010;17:291303.
  • 79
    Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, et al.Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med2004;169:12038.
  • 80
    Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, et al.Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.Am J Respir Crit Care Med2004;170:24251.